Investment Firm Increases Stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 10.0%
Are you interested in investing in healthcare stocks? If so, you may want to take a closer look at Pediatrix Medical Group, Inc. (NYSE:MD). This company, which provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States, has recently caught the attention of several large investors.
Charles Schwab Investment Management Inc. recently increased its stake in Pediatrix Medical Group by 10.0% in the 4th quarter, showing confidence in the company’s potential. Other notable investors, such as Teacher Retirement System of Texas, Victory Capital Management Inc., and Illinois Municipal Retirement Fund, have also made significant investments in Pediatrix Medical Group.
Despite the recent investments from institutional investors, Pediatrix Medical Group’s stock has seen a slight decline of 1.7%. However, analysts remain optimistic about the company’s future prospects. In its most recent quarterly earnings report, Pediatrix Medical Group exceeded analysts’ expectations, reporting earnings per share of $0.17.
Several research analysts have weighed in on Pediatrix Medical Group’s stock, with most maintaining a “hold” rating. The consensus target price for the stock is $9.38, indicating potential upside for investors.
If you’re considering adding Pediatrix Medical Group to your investment portfolio, it’s essential to conduct thorough research and stay informed about the company’s latest news and developments. By subscribing to MarketBeat.com’s daily email newsletter, you can receive timely updates and analysis on Pediatrix Medical Group and other related companies.
Overall, Pediatrix Medical Group presents an intriguing investment opportunity in the healthcare sector. With a strong focus on newborn and pediatric care services, the company is well-positioned for future growth and success. Keep an eye on Pediatrix Medical Group as it continues to make strides in the healthcare industry.